NCT00841451 (PUFA) is a clinical trial of Lovaza (Fish Oils) in Atrial Fibrillation, sponsored by St. Luke's-Roosevelt Hospital Center.

Who is sponsoring NCT00841451?

NCT00841451 is sponsored by St. Luke's-Roosevelt Hospital Center.

What drugs are being tested in NCT00841451?

Interventions in NCT00841451: Lovaza (Fish Oils).

What condition does NCT00841451 study?

NCT00841451 studies Atrial Fibrillation.

Is NCT00841451 still recruiting?

NCT00841451 is currently no longer available. Last updated 23 March 2016.

Last reviewed 2016-03-23 · How we verify

NCT00841451: PUFA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pulmonary Vein Isolation Outcomes With Fish Oils

NO LONGER AVAILABLE Last updated 23 March 2016

What this trial tests

trial testing Lovaza (Fish Oils) in Atrial Fibrillation. No longer available.

Quick facts

Lead sponsor	St. Luke's-Roosevelt Hospital Center
Status	NO LONGER AVAILABLE
Study type	EXPANDED_ACCESS
Sites	3 locations across United States

Drugs / interventions tested

Lovaza (Fish Oils) — full drug profile →

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

St. Luke's-Roosevelt Hospital Center

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fish oil therapy may decrease the incidence of cardiac arrhythmias. This study will test whether pre-treatment with fish oils before catheter ablation of atrial fibrillation decreases the early post operative occurrence of atrial fibrillation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other St. Luke's-Roosevelt Hospital Center trials

Trials by the same sponsor.

NCT02159807 — Optimizing Dose of Bupivacaine in Combined Spinal Epidurals To Reduce Side Effects · NA · completed
NCT03195712 — Metabolically Healthy Obesity: Correlations Between BMI and Metabolic Syndrome Biomarkers · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00841451 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Luke's-Roosevelt Hospital Center
Last refreshed: 23 March 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00841451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing